<DOC>
	<DOCNO>NCT02745951</DOCNO>
	<brief_summary>The HELICOPTER-1 Trial single centre pilot study determine feasibility administer Heliox cardioplegia cardiac surgery whether potential reduce incidence severity myocardial ischemia cardiac surgery .</brief_summary>
	<brief_title>HELIox CardiOPlegia Trial During Cardiac surgERy</brief_title>
	<detailed_description>The HELICOPTER-1 Trial single centre , randomize trial evaluate feasibility administration Heliox prevention myocardial ischemia patient undergoing cardiac surgery . Half study population randomly assign receive cardioplegia enrich 70:30 ( Helium : Oxygen ) Heliox mixture , half randomize receive current clinical standard care ( nitrogen oxygen cardioplegia ) . Subjects follow daily post-operative course hospital clinical outcome . A 30-day phone follow-up conduct vital status MI .</detailed_description>
	<criteria>Age 18 old Cardiac surgery CPB use coronary sinus catheter indicate Patient refusal Recent myocardial infarction ( le 7 day old ) Left ventricular ejection fraction le 30 % Known pregnancy date surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>cardiopulmonary bypass</keyword>
	<keyword>cardioplegia</keyword>
	<keyword>cardioprotection</keyword>
	<keyword>coronary artery bypass graft surgery</keyword>
	<keyword>heliox</keyword>
</DOC>